ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹6,862 Cr | ₹6,810 Cr | ₹3,472 Cr | ₹2,113 Cr | ₹1,703 Cr |
What is the latest Total Liabilities ratio of ERIS LIFESCIENCES ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹6,862 Cr |
Mar2024 | ₹6,810 Cr |
Mar2023 | ₹3,472 Cr |
Mar2022 | ₹2,113 Cr |
Mar2021 | ₹1,703 Cr |
How is Total Liabilities of ERIS LIFESCIENCES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹6,862 Cr | 0.76 | |
Mar2024 | ₹6,810 Cr | 96.16 | |
Mar2023 | ₹3,472 Cr | 64.33 | |
Mar2022 | ₹2,113 Cr | 24.07 | |
Mar2021 | ₹1,703 Cr | - |
Compare Total Liabilities of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹22,347.7 Cr | -1.6% | -6.7% | 17.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | -1.6% |
-6.7% |
17.7% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses